These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9434317)

  • 1. Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1.
    Kim SH; Han KS; Choi WS; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):77-84. PubMed ID: 9434317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability, blood partition, and pharmacokinetics of a new proton pump inhibitor, YJA-20379-8.
    Chung SY; Han KS; Chung YK; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):187-200. PubMed ID: 9667073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH; Lee MG
    Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic changes of a new proton pump inhibitor, YJA-20379-8, after intravenous and oral administration to rats with uranyl nitrate-induced acute renal failure.
    Kim HJ; Han KS; Chung YK; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Oct; 102(1):43-56. PubMed ID: 9920345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
    Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a new proton pump inhibitor, YJA-20379-8, in rats with 48-hour water deprivation.
    Kim HJ; Han KS; Chung YK; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):137-46. PubMed ID: 9821210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacological properties of YJA 20379-1, a novel proton pump inhibitor with antiulcer activities.
    Lee EB; Cho SI; Cheon SA; Chang MS; Kim KB; Sohn SK; Chung YK
    Arzneimittelforschung; 1999 Dec; 49(12):1018-24. PubMed ID: 10635448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH; Lee MG
    Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor.
    Shim HJ; Lee EJ; Kim SH; Kim SH; Yoo M; Kwon JW; Kim WB; Lee HS; Lee MG
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):275-86. PubMed ID: 11913718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a novel antiangiogenic agent KR-31831 in rats.
    Kim SJ; Lee HI; Ji HY; Moon Y; Paek IB; Lee S; Yi KY; Yoo SD; Lee HS
    Biopharm Drug Dispos; 2005 Jan; 26(1):21-6. PubMed ID: 15578734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
    Kim J; Kim EJ; Han KS; Chang MS; Lee MG
    J Pharm Pharmacol; 1999 Sep; 51(9):1031-6. PubMed ID: 10528986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability.
    Chung HJ; Lee JH; Woo SJ; Park HK; Koo CH; Lee MG
    Biopharm Drug Dispos; 2007 May; 28(4):187-97. PubMed ID: 17377948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS; Bae SK; Lee MG
    Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
    Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS
    Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
    Lee JH; Shin JH; Lee MG
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():203-15. PubMed ID: 17564318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of verproside after intravenous and oral administration in rats.
    Park EJ; Lee HS; Oh SR; Lee HK; Lee HS
    Arch Pharm Res; 2009 Apr; 32(4):559-64. PubMed ID: 19407974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.
    Chung HJ; Choi YH; Choi HD; Jang JM; Shim HJ; Yoo M; Kwon JW; Lee MG
    Eur J Pharm Sci; 2006 Mar; 27(4):363-74. PubMed ID: 16387482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal absorption of a new reversible proton pump inhibitor, YJA-20379-8, and its pharmacokinetics after oral administration in acetic acid-induced gastric ulcer in rats.
    Chung SY; Han KS; Kim HJ; Kim J; Chang MS; Lee MG
    J Pharm Pharmacol; 1999 Sep; 51(9):1025-30. PubMed ID: 10528985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of a new proton-pump inhibitor, YJA-20379-8, after intravenous and oral administration to rats with streptozotocin-induced diabetes mellitus.
    Chung SY; Han KS; Shon SK; Chang MS; Lee MG
    J Pharm Pharmacol; 1999 Aug; 51(8):929-34. PubMed ID: 10504032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.